S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
The $193 Billion US-China War You Don't Know About (Ad)
Is Frontline's 20% Dividend Too Good To Be True?
3 Reasons The Wayfair Rally Is Way Overdone
The $193 Billion US-China War You Don't Know About (Ad)
Stock market today: World stocks mixed as Wall St inches toward bull market
Wheat prices jump following collapse of major dam in southern Ukraine
The $193 Billion US-China War You Don't Know About (Ad)
Here’s What’s Driving the Price of Carvana Higher
Tesla: How and Why It Gets To $300
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
The $193 Billion US-China War You Don't Know About (Ad)
Is Frontline's 20% Dividend Too Good To Be True?
3 Reasons The Wayfair Rally Is Way Overdone
The $193 Billion US-China War You Don't Know About (Ad)
Stock market today: World stocks mixed as Wall St inches toward bull market
Wheat prices jump following collapse of major dam in southern Ukraine
The $193 Billion US-China War You Don't Know About (Ad)
Here’s What’s Driving the Price of Carvana Higher
Tesla: How and Why It Gets To $300
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
The $193 Billion US-China War You Don't Know About (Ad)
Is Frontline's 20% Dividend Too Good To Be True?
3 Reasons The Wayfair Rally Is Way Overdone
The $193 Billion US-China War You Don't Know About (Ad)
Stock market today: World stocks mixed as Wall St inches toward bull market
Wheat prices jump following collapse of major dam in southern Ukraine
The $193 Billion US-China War You Don't Know About (Ad)
Here’s What’s Driving the Price of Carvana Higher
Tesla: How and Why It Gets To $300
S&P 500   4,283.85
DOW   33,573.28
QQQ   354.84
High Dividend REITs: Are They an Ideal Way to Diversify?
The $193 Billion US-China War You Don't Know About (Ad)
Is Frontline's 20% Dividend Too Good To Be True?
3 Reasons The Wayfair Rally Is Way Overdone
The $193 Billion US-China War You Don't Know About (Ad)
Stock market today: World stocks mixed as Wall St inches toward bull market
Wheat prices jump following collapse of major dam in southern Ukraine
The $193 Billion US-China War You Don't Know About (Ad)
Here’s What’s Driving the Price of Carvana Higher
Tesla: How and Why It Gets To $300
NASDAQ:ABEO

Abeona Therapeutics (ABEO) News Today

$4.00
-0.03 (-0.74%)
(As of 06/6/2023 ET)
Compare
Today's Range
$3.72
▼
$4.20
50-Day Range
$2.76
▼
$4.03
52-Week Range
$2.19
▼
$6.13
Volume
202,898 shs
Average Volume
136,305 shs
Market Capitalization
$75.12 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$22.00
ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability
Get Abeona Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter.



ABEO Media Mentions By Week

ABEO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ABEO
News Sentiment
▼
0.46

0.52
▲
Average
Medical
News Sentiment

ABEO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ABEO Articles
This Week
▼
4

1
▲
ABEO Articles
Average Week

SourceHeadline
MarketBeat logoAbeona Therapeutics Inc (NASDAQ:ABEO) Expected to Post Q2 2023 Earnings of ($0.66) Per Share
americanbankingnews.com - June 2 at 7:25 AM
msn.com logoABEO: Additional Phase 3 VIITAL™ Data Presented at ISID Meeting
msn.com - May 30 at 2:30 PM
finance.yahoo.com logoABEO: Additional Phase 3 VIITAL™ Data Presented at ISID Meeting
finance.yahoo.com - May 30 at 2:30 PM
MarketBeat logoAbeona Therapeutics Inc (NASDAQ:ABEO) Short Interest Update
americanbankingnews.com - May 29 at 1:40 AM
finance.yahoo.com logoQ1 2023 Abeona Therapeutics Inc Earnings Call and Portfolio Update Conference Call
finance.yahoo.com - May 25 at 8:33 AM
seekingalpha.com logoAbeona Therapeutics Q1 2023 Earnings Preview
seekingalpha.com - May 23 at 4:00 PM
finance.yahoo.com logoAbeona Therapeutics Announces Date Change for First Quarter 2023 Portfolio Update Conference Call to May 24, 2023
finance.yahoo.com - May 22 at 8:13 AM
MarketBeat logoAbeona Therapeutics (ABEO) Set to Announce Quarterly Earnings on Tuesday
americanbankingnews.com - May 22 at 7:50 AM
MarketBeat logoAbeona Therapeutics (NASDAQ:ABEO) Now Covered by Analysts at StockNews.com
americanbankingnews.com - May 19 at 6:54 AM
finance.yahoo.com logoAbeona Therapeutics Announces New Preclinical Data from its AAV Ophthalmology Program at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
finance.yahoo.com - May 16 at 4:56 PM
MarketBeat logoShort Interest in Abeona Therapeutics Inc (NASDAQ:ABEO) Decreases By 14.8%
americanbankingnews.com - May 14 at 6:00 AM
finance.yahoo.com logoAbeona Therapeutics First Quarter 2023 Earnings: US$0.54 loss per share (vs US$3.59 loss in 1Q 2022)
finance.yahoo.com - May 13 at 12:57 PM
msn.com logoAbeona stock rises on new data for rare skin disorder drug EB-101
msn.com - May 12 at 9:36 AM
finanznachrichten.de logoAbeona Therapeutics Inc.: Abeona Therapeutics Reports First Quarter 2023 Financial Results
finanznachrichten.de - May 11 at 8:33 AM
finance.yahoo.com logoAbeona Therapeutics Announces Additional Phase 3 VIITAL™ Study Results for EB-101 Presented at the International Societies for Investigative Dermatology 2023 Meeting
finance.yahoo.com - May 11 at 8:33 AM
finance.yahoo.com logoAbeona Therapeutics Reports First Quarter 2023 Financial Results
finance.yahoo.com - May 11 at 8:33 AM
MarketBeat logoAbeona Therapeutics (NASDAQ:ABEO) vs. Nurix Therapeutics (NASDAQ:NRIX) Critical Comparison
americanbankingnews.com - May 11 at 4:26 AM
MarketBeat logoAbeona Therapeutics (ABEO) Scheduled to Post Quarterly Earnings on Thursday
americanbankingnews.com - May 10 at 8:44 AM
MarketBeat logoAbeona Therapeutics (ABEO) Set to Announce Quarterly Earnings on Thursday
americanbankingnews.com - May 10 at 8:02 AM
marketwatch.com logoAntimicrobial Peptides Market Size and volume sale report 2023
marketwatch.com - May 5 at 7:49 PM
MarketBeat logoShort Interest in Abeona Therapeutics Inc (NASDAQ:ABEO) Drops By 19.9%
americanbankingnews.com - April 30 at 5:58 AM
marketwatch.com logoIntracranial Therapeutic Market Size By 2030
marketwatch.com - April 28 at 1:18 PM
MarketBeat logoZacks Small Cap Comments on Abeona Therapeutics Inc's Q1 2023 Earnings (NASDAQ:ABEO)
americanbankingnews.com - April 23 at 1:40 AM
MarketBeat logoAbeona Therapeutics Inc (NASDAQ:ABEO) Sees Significant Growth in Short Interest
americanbankingnews.com - April 19 at 7:22 AM
finance.yahoo.com logoABEO: Initiating Coverage of Abeona Therapeutics Inc.; Using Gene Therapy to Treat Orphan Diseases…
finance.yahoo.com - April 18 at 1:10 PM
tmcnet.com logoAbeona Therapeutics Announces Multiple Abstracts Accepted from its
tmcnet.com - April 10 at 10:42 AM
finance.yahoo.com logoAbeona Therapeutics Announces Multiple Abstracts Accepted from its AAV Ophthalmology Program at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
finance.yahoo.com - April 10 at 10:42 AM
marketwatch.com logoAlpha-1 Antitrypsin Drugs Market Forecast to 2030
marketwatch.com - April 7 at 8:40 AM
seekingalpha.com logoABEO Abeona Therapeutics Inc.
seekingalpha.com - March 31 at 6:45 PM
finance.yahoo.com logoCompanies Like Abeona Therapeutics (NASDAQ:ABEO) Could Be Quite Risky
finance.yahoo.com - March 31 at 8:00 AM
finanznachrichten.de logoAbeona Therapeutics Inc.: Abeona Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update
finanznachrichten.de - March 29 at 2:00 PM
msn.com logoAbeona Therapeutics GAAP EPS of -$5.53 misses by $1.61, revenue of $1.41M misses by $0.91M
msn.com - March 29 at 8:59 AM
finance.yahoo.com logoAbeona Therapeutics Reports Full Year 2022 Financial Results and Provides Corporate Update
finance.yahoo.com - March 29 at 8:59 AM
MarketBeat logoAbeona Therapeutics (ABEO) to Release Earnings on Wednesday
americanbankingnews.com - March 28 at 9:02 AM
marketwatch.com logoAntimicrobial Peptides Market Size 2023 | Dynamics, Supply-Demand and Growth Rate Analysis by 2028
marketwatch.com - March 27 at 12:25 PM
MarketBeat logoAbeona Therapeutics (NASDAQ:ABEO) Shares Cross Above 50-Day Moving Average of $2.54
americanbankingnews.com - March 26 at 7:22 AM
finance.yahoo.com logoAbeona Therapeutics Announces New Employee Inducement Grants
finance.yahoo.com - March 24 at 8:00 AM
marketwatch.com logoAntimicrobial Peptides Market: The Growing Trend 2030
marketwatch.com - March 21 at 3:46 PM
finance.yahoo.com logoAbeona Therapeutics Announces Acceptance of Abstract on EB-101 Phase 3 VIITAL™ Study Results for Oral Presentation at International Societies for Investigative Dermatology (ISID) 2023 Meeting
finance.yahoo.com - March 16 at 8:07 AM
marketwatch.com logoPolymer Drug Conjugates Market Application, Product, Sales and Forecast 2023-2028
marketwatch.com - March 15 at 8:27 AM
finance.yahoo.com logoAbeona Therapeutics Announces Update on AAV Ophthalmology Program
finance.yahoo.com - March 14 at 10:43 AM
marketwatch.com logoGlobal Alpha 1 Antitrypsin Deficiency Treatment Market 2023 Revenue, Competitive Dynamics, Advancement, and Forecast to 2030 By VMReports
marketwatch.com - March 10 at 5:42 AM
marketwatch.com logoAlpha-1 Antitrypsin Drugs New Investments Expected to Boost the Demand by 2028
marketwatch.com - March 3 at 3:46 PM
marketwatch.com logo2023 Latest Genetic Modification Therapies Market Research: Pricing Strategy and Analysis for PRODUCT TYPE by 2028
marketwatch.com - February 23 at 8:08 AM
finance.yahoo.com logoGenetic Chronic Obstructive Pulmonary Disease (COPD) Market to Surpass US$ 720.5 Million by 2030, Says Coherent Market Insights (CMI)
finance.yahoo.com - February 20 at 10:20 AM
marketwatch.com logoAlpha-1 Antitrypsin Drugs Market by Top Manufacturers, Growing Demand and Supply 2023-2028
marketwatch.com - February 18 at 9:18 AM
marketwatch.com logoPolymer Drug Conjugates Market Massive Growth Strikes Due To Technological Innovation During 2023-2028
marketwatch.com - February 14 at 8:27 AM
marketwatch.com logoMucopolysaccharidosis Therapeutics Market 2023 Assessed to See Remarkable Growth till 2028 | Says Absolute Reports Experts
marketwatch.com - February 14 at 8:27 AM
marketwatch.com logoAlpha 1 Antitrypsin Deficiency Treatment Market Latest Research Report with Growth Projection and top Industry Analysis 2023-2028
marketwatch.com - February 7 at 8:06 AM
marketwatch.com logoAlpha-1 Antitrypsin Drugs Market Provides an In-Depth Insight of Trends and Landscape Outlook 2023-2028
marketwatch.com - January 26 at 1:55 AM
Get Abeona Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ABEO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

Related Companies:
Headlines Tools:
This page (NASDAQ:ABEO) was last updated on 6/7/2023 by MarketBeat.com Staff

My Account -